No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Umbralisib is a drug used to treat certain types of lymphoma, a type of cancer that affects the lymphatic system. It is a kinase inhibitor, meaning it works by blocking certain proteins that help cancer cells grow and divide. It is approved for use in combination with other drugs to treat certain types of non-Hodgkin lymphoma, including marginal zone lymphoma and follicular lymphoma. It is also being studied for use in other types of cancer, such as chronic lymphocytic leukemia and multiple myeloma.
Umbralisib is a relatively new drug, and is still in the early stages of development. It is being studied in clinical trials to evaluate its safety and effectiveness in treating various types of cancer. It is also being studied in combination with other drugs to see if it can improve outcomes for patients.
The umbralisib market is a rapidly growing one, with many companies developing and marketing the drug. Some of the companies in the market include Gilead Sciences, AbbVie, and Novartis. Show Less Read more
